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Although considerable information has accumulated to indi-
cate a key role for mononuclear phagocytes in the effector limb 
of cell-mediated immunity [1-5), relatively little is known about 
the biochemical mechanisms which underlie the broad range of 
activities displayed by these cells. Monocytes, macrophages, 
thymus-derived (T) lymphocytes, and especially their interac-
tion have all been implicated in host responses to a variety of 
immunologic stimuli including microbial pathogens and malig-
nant neoplasms [5]. In addition, this cellular immune system 
also appears to interact in a complex fashion with humoral 
components (immunoglobulins, complement proteins, immune 
complexes, coagulation factors) in both microbe and tumor cell 
killing and in related processes such as inflammation and graft 
rejection. Efforts to characterize the mechanisms subtending 
the protean activities of mononuclear phagocytes have explored 
a variety of cellular functions , and increasing attention is now 
being focused on oxygen-dependent systems. Recent work in 
this laboratory has been directed at examining mononuclear 
phagocyte generation of reactive oxygen intermediates and the 
role of these products in macrophage antimicrobial and anti-
tumor activity. Although our observations are derived primarily 
from the mouse peritoneal macrophage model, similar findings 
are currently being made with human monocytes as well. 
OXIDATIVE CAPACITY OF MACROPHAGES 
While both the capacity of polymorphonuclear leukocytes 
(PMN) to generate oxidative metabolites and the importance 
of these toxic products in PMN bacterial killing have been 
apparent for over a decade [6-8], only recently has it become 
clear that mononuclear phagocytes share similar oxidative pow-
ers. After appropriate activation and subsequent plasma mem-
brane perturbation, monocytes and macrophages consume ox-
ygen and promptly generate superoxide anion (02- ), hyd.l·ogen 
peroxide (H20 2), hydroxyl radical (OH ·) and probably singlet 
oxygen ('02) [9-12]. This respiratory metabolic burst may be 
triggered in vitro by a variety of stimuli including soluble 
membrane-active agents (phorbol myristate acetate (PMA) and 
endotoxin), contact with complement proteins or nonphagocy-
tosable smfaces coated with immunoglobulin or immune com-
plexes, or phagocytosis of microbes or inert test particles 
[9,10,13]. o2- is formed by the partial reduction of molecular 
oxygen and H 20 2 arises by the spontaneous or superoxide 
dismutase (SOD) catalyzed dismutation of 02- . Although the 
pathways(s) by which OH. and 10 2 are produced have not been 
fJrmly established, it appears likely that these latter more distal 
intermediates are formed by the interaction of 0 2- and H20 2 
[14]. 
Current techniques permit quantitation of only the extracel-
lularly released portion of the 0 2- , H 20 2, and OH· generated 
by phagocytic cells, and thus, have not allowed characterization 
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of oxidative events within phagocytic vacuoles. It is probable, 
however, that the 0 2- generating system is sufficiently proxi-
mate to the plasma membrane to result in simultaneous extra-
cellular release and intra vacuolar delivery of 0 2- · H 20 2 detected 
extracellularly appears to be primarily derived from 0 2- initially 
released into the sunounding medium [10]. No doubt some of 
the intracellularly generated H z0 2 also diffuses outside the cell 
as well [15]. Extracellular OH · and 10 2 are presumably formed 
by similar mechanisms. No matter the original site of produc-
tion, once delivered these toxic oxidative metabolites may injme 
or kill a variety of both intra and extracellular targets by 
disrupting membranes via lipid peroxidation, protein denatur-
ation, or by interacting with target cell constituents to produce 
still other potentially deleterious products [17). 
It should also be pointed out that unlike macrophages mon-
ocytes contain myeloperoxidase. Thus, similar to PMN's, mon-
ocytes possess an additional oxygen-dependent system which 
in the presence of an oxidizable halide cofactor may serve to 
augment the toxicity of H 20 2 [17). 
Oxygen Intermediates in Mononuclear Phagocyte 
Antimicrobial Activity 
Evidence suggesting a role for oxygen-dependent systems in 
mononuclear cell microbicidal activity first stemmed from sev-
eral previous observations. Monocytes from patients with 
cluonic granulomatous disease (CGD) exhibit oxidative and 
bactericidal defects similar to those seen with CGD PMN's 
[17], and exposing normal human monocytes to an 0 2- scav-
enger (SOD) at the time of S. aureus ingestion reduces staph-
ylococcal killing [18]. Monocytes from patients with hereditary 
myeloperoxidase deficiency also fail to kill certain Candida 
species normally [17]. Depriving macrophages of oxygen, how-
ever, has yielded conflicting results in terms of inhibiting bac-
tericidal activity [19]. Since macrophages are of particular 
importance in host resistance to intracellular pathogens, we 
have explored the role of oxygen intermediates in both a cell-
free system and a macrophage model using two such organisms, 
·Toxoplasma gondii [20,21] and Trypanosoma cruzi [22). 
Cell Free System 
When exposed to glucose and glucose oxidase (GO) , a reaction 
· which produces no oxygen intermediates other than H 20 2, 
trypanosomes are rapidly killed [22). In contrast, toxoplasmas 
are resistant to fluxes of H 20 2 (8-10 nmoles/ min) generated by 
similar amounts of GO and remain viable despite exposme to 
up to 10- 3 M reagent H 20 2 [20]. A likely explanation for varying 
sensitivity to H 20 2 is endogenous parasite catalase which try-
panosomes lack and toxoplasmas abundantly possess. In the 
presence of a peroxidase and halide, however, toxoplasmas are 
promptly killed by as little as 10- 5 M H20 2 [20). 
The toxicity of other oxygen intermediates has been further 
investigated by exposing toxoplasmas to xanthine and xanthine 
oxidase. This reaction generates 0 2- , H 20 2, OH · and probably 
10 2 [14], and thus, is conveniently analogous to the cellular 
oxidative events initiated by phagocytosis. After brief exposure 
to xanthine-xanthine oxidase, the bulk of toxoplasmas in sus-
pension were readily killed. Evidence for the participation of 
oxygen intermediates in this system was demonstrated by the 
inhibition of parasite killing by scavengers of 0 2- (SOD), H 20 2 
(catalase), OH · (mannitol, benzoate), and 10 2 (DABCO, histi-
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dine). Since both SOD and catalase prevented toxoplasma 
killing, neither Oz- nor Hz0 2 could be implicated as toxic agents. 
The requirement for both metabolites for toxoplasmacidal ac-
tivity, however, suggested a key role for products of Oz- - HzOz 
interaction. Observing that scavengers of OH. and quenchers 
of 10 2 also effectively reversed xanthine oxidase parasite killing 
indicated that 0 2- and Hz0 2 functioned importantly as precur-
sors, but that more distal intermediates in the reduction of 
oxygen such as OH· and 10 2 were toxoplasmacidal (21). 
MACROPHAGE-PARASITE MODEL 
In Vivo Activated Cells 
We have also reported similar data indicating a role for an 
oxygen-dependent system in the antimicrobial activity of mac-
rophages activated both in vivo and in vitro. Cultivated resident 
peritoneal macrophages from normal mice allow unrestricted 
growth of both T. gondii [21] and T. cruzi [22]. In response to 
phagocytic (zymosan particles) or membrane-activating stimuli 
such as PMA, these cells release little 0 2- or Hz0 2 [9,10]. 
Macrophages from immune mice, however, exhibit microbi-
static activity against the respective organism, and in the case 
of toxoplasma immune mice, release approximately 4X more 
H20 2 than normal cells. In contrast, peritoneal macrophages 
from immune mice further activated in vivo by boosting with 
homologous microbe antigen are distinctly microbicidal. In the 
toxoplasma model, these immune-boosted cells release up to 
25x more H20 2 after PMA triggering than macrophages from 
normal mice [21]. Thus, there appears to be a direct correlation 
between the capacity of the macrophage to generate oxidative 
metabolites (as judged by extracellular release of HzOz) and 
their ability to influence the intracellular fate of these patho-
gens. 
Further evidence indicating the importance of an oxygen-
dependent system in macrophage antitoxoplasma activity was 
derived by exposing microbistatic (immune) and microbicidal (immune-boosted) cells to oxygen intermediates scavengers. 
Treatment with scavengers of 0 2- , Hz0 2, OH · and 10 2 all 
resulted in clear reversal of macrophage in vitro anti toxoplasma 
activity, providing firm evidence for the participation of oxida-
tive metabolites (21]. Similar to our findings in the cell-free 
model, these observations also suggested that radicals more 
distal to Oz- and H 20 2 were active against intracellular toxo-
plasmas. OH · and 10 2 appear to be likely agents (21]. Depriving 
immune and immune-\.lOosted macrophages of glucose, a tech-
nique which ablates Hz02 release [23], also reversed the capac-
ity to inhibit or kill intracellular toxoplasmas. Finally, providing 
non-immune, resident macrophages from normal mice with an 
exogenous source of oxygen intermediates other than H20 2 (by 
adding xanthine-xanthine oxidase after parasite ingestion to the 
extracellular medium) also resulted in inhibition of intracellular 
toxoplasma multiplication [21]. 
In Vitro Activated Cells 
The contribution of oxidative metabolism to the antimicro-
bial activity of macrophages activated in vitro has also been 
examined by exposing resident or proteose-peptone elicited 
peritoneal cells from normal mice to lymphocyte products (lymphokines) . These soluble products were generated in a 
standard fashion by cocultivation of sensitized spleen lympho-
cytes from immunized mice with specific microbial antigen [21,22]. In the T. cruzi model, daily addition of fresh lympho-
kine to macrophage monolayers before and after infection re-
sulted in a progressive enhancement of H20 2 release after PMA 
triggering and simultaneous eradication of intracellular trypan-
osomes [22). In the T. gondii system, lyrnphokine treatment 
resulted in comparably augmented H20 2 release, but no induc-
tion of anti toxoplasma activity. This discrepancy between stim-
ulation of macrophage oxidative metabolism and no apparent 
enhancement of antimicrobial capacity by in vitro activating 
techniques is currently being investigated, and may be related 
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to the varying susceptibilities of these two intracellular para-
sites to oxygen intermediates. 
OXIDATIVE METABOLISM IN MONONUCLEAR 
PHAGOCYTE ANTITUMOR ACTIVITY 
Sufficient evidence has also accumulated from studies of both 
animal and human cells to suggest that mononuclear phago-
cytes are important participants in the host response to tumor 
cell growth [24]. Activation of the monocyte-macrophage-T 
lymphocyte system by immunologic adjuvants or du·onic infec-
tions confers not only enhanced in vivo resistance to microbial 
pathogens but to various tumors as well [ 4,5]. Cytotoxic mac-
rophages and monocytes can also be induced in vitro by specific 
and nonspecific stimuli such as endotoxin treatment or exposure 
to soluble mediators (lymphokines) released by antigen- or 
mitogen-stimulated T lymphocytes [25-27]. As we and others 
have shown, lyrnphokine treatment also influences a v~U'iety of 
other cellular and biologic functions including enhancement of 
antimicrobial activity and release of oxygen intermediates. Re-
cent studies using PMN's have also demonstrated that these 
phagocytes may be potent cytotoxic cells as well [16,28]. 
Although phagocytosis does not occur, close contact between 
effector macrophages and target cells appears to be required 
for macrophage-mediated tumor cell killing (25]. Antibody-de-
pendent cell-mediated cytotoxicity (ADCC) is one such model 
by which monocytes bearing Fe receptors may bind to and 
subsequently lyse immunoglobulin-coated tumor cells (29]. 
However, the actual biochemical mechanisms which monocytes 
and activated macrophages utilize in the recognition and de-
struction of extracellular targets such as mammalian neoplastic 
cells have until recently been largely unexplored. 
Secretion of thymidine and arginase may account for some of 
the in vitro cytostatic and cytolytic effects of macrophages; 
however, it is unlikely that these molecules mediate similar 
effects in vivo [30]. A role for products of the oxidative meta-
bolic burst has been suggested in tumor cell killing since enzy-
matically generated and reagent Hz0 2 (with or without a per-
oxidase and halide) can effectively lyse mammalian cells in 
vitro [30,31]. Moreover, the results of several recent studies 
using human PMN's have indicated that extracellular release 
of oxygen intermediates such as 0 2- and H20 2 form an effective 
system against tumor cells [16,28]. In certain of these in vitro 
PMN-tumor cell models, myeloperoxidase and an oxidizable 
halide cofactor are required for effective target cell lysis [28]. 
In this laboratory, Dr. Carl F. Nathan has demonstrated in 
an antibody-free system that after in vivo activation and in 
vitro triggering, macrophages release copious amounts of H20 2 
and that this intermediate alone is sufficient for extracellular 
cytolysis (23,30]. When incubated with P388 lymphoma cells, 
cultivated macrophages from BCG-infected mice fail to release 
H20 2 or kill the tumor cells in the absence of a triggering agent. 
Upon the addition of PMA, however, these macrophages 
promptly released H20 2 and readily lysed the P388 targets 
within 4-6 hr. Procedures which ablated the phagocyte oxida-
tive metabolic burst including anaerobiosis and glucose depri-
vation abrogated the ability of BCG-activated macrophages to 
lyse the tumor cells. Catalase and ferricytochrome C (which 
oxidizes 0 2·· , the precursor of H 20 z) markedly reduced macro-
phage cytotoxicity, while SOD (which scavenges 0 2- by pro-
moting its dismutation to Hz0 2) enhanced cytotoxicity. Scav-
engers of OH· and quenchers of 10 z had no effect on P388 cell 
killing suggesting that these latter intermediates played no role 
in this system. Exposing P388 tumor cells to starch particles 
covalently coupled with glucose oxidase (GO) in amounts that 
generated fluxes of H20 2 similar to BCG-activated cells (2-4 
nmoles H20z/5 min) resulted in cytolysis comparable to that 
observed with PMA-triggered macrophages. Catalase abolished 
the cytotoxicity of particle-bound GO. Finally, no evidence for 
a peroxidase-mediated effect could be demonstrated. Macro-
phages were negative cytochemically for peroxidase, and per-
oxidase inhibitors (azide, cyanide) failed to decrease cytotoxic-
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ity. Thus, in this macrophage-tumor cell system, H20 2 gener-
ated enzymatically or released after triggering of activated 
macrophages was both necessary and sufficient for extracellular 
cytolysis of lymphoma cells. 
CONCLUSION 
The studies briefly outlined here illust rate the broad range 
of techniques currently available for investigating cellular oxi-
dative metabolism. The observations from this laboratory pro-
vide fir m evidence for the par t icipation of an oxygen-dependent 
system in mononuclear phagocyte ant imicrobial and ant itumor 
activity. It appears likely that the generation of toxic oxygen 
intermediates plays an important role in macrophage i·esistance 
to intracellular par asites such as T. cruzi and T. gondii. Our 
studies with these two micro-organisms also suggest that there 
m ay be significan t variation in parasite suscept ibility to oxid~ ­
t ive metabolites. Moreover, persistent intracellular parasitiza-
t ion of certain cells may be related to the inability to generate 
or deliver either suffic ient concentrations of toxic intermediates 
or par t icular metabolites requil·ed to kill a specific pathogen. 
E xtracellular release of oxygen intermediates also appears to 
be an important mechanism underlying tumor cell killing by 
activa ted macrophages. 
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DISCUSSION 
GREEN: Can activated macrophages or the degree of macrophage 
activation be measm ed in vivo in disease states? T his may be the next 
step in understanding the role of active macrophages in disease etiology. 
CoH N: It depends upon what you m ean by activation. If you mean 
the increase of a certain enzyme or the absence of a certain enzyme, I 
a m sm e you could do t his. In terms of some of the more impor tant 
physiological functions of the activated cell , such as microbicidal and 
tumorcidal, one can do this in a rather general way by doing organ 
counts, such as George Mackiness and his colleagues have done for 
many yeru·s. At a more specific level, though, I think it is rather difficult. 
I t br ings up a nother question a nd that is, do we have any specific 
marker fo r the macrophage sw·face? I would have to answer no, we do 
not. We know of no specific differentiation antigen in the macrophage 
and this obviously would be of great importance to know. 
BRODY: Can you amplify the kinds of ratios of activated macro phages 
and tumor cells required to achieve tumor cell killing? More specifically, 
if one increases the numbers of tumor cells per activated macrophage 
does one see a decrease in the effectiveness of tumor cell killing? Does 
one also see a decrease in the state of activity of the macrophages? In 
other words, is there any evidence that tumor cells produce a material 
that can disru·m the macrophage? 
CoHN : T he usual mult iplicities employed in these studies range from 
1 to 1, with which one gets appreciable k illing to as much as 20 to 1, 
wi th which one gets complete destruction. T umors vru·y in t heir sensi-
t ivi ty to both killing and to killing by nacent hydrogen peroxide in the 
mouse system, a nd there seems to be a good correlation between these 
two. Whether this is related to other pathways that ut ilize hydrogen 
peroxide in the tumor cell , catalase being an appru·ent one, peroxide 
being another, is uncleru· at this poin t. T hese multiplicit ies, by the way, 
I think ru·e somewhat lower than in many lymphoid systems. 
GIGLI : T he tinding that you ca n precipitate iodinated Factor B with 
an t ibodies to Factor B would imply that the macrophage makes Factor 
B . 
CoHN: It makes a polypeptide with the appropriate molecular weight 
which is precipitated by the antibody. 
GIGLI : Do you have evidence fo r processing of complement compo-
nents during membran e transport of the complement proteins? 
COHN: One of the problems is that we do not know where Factor B 
is in fact associated wi th the membrane. Is it inserted as an integral 
protein, is it merely a bsorbed? Is it first excreted in to the medium a nd 
then bound by some sor t of receptor? Is it bound and then in teriorized 
and activated, let's say, in the secondary lysosome and cycled back to 
the surface in active form? T here ru·e a variety of th ings we do not 
know. 
GJGLI : But wouldn 't the iodinization imply that it has to be an active 
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sy nthetic process rather than absorption, interiorization and excretion? 
CoHN: It would suggest that at least it is a product of the macrophage 
but how recent a product is unclear. We would have to do S-35 
methionine studies to answer that. 
G JGLJ: Does plasminogen activator production by macrophages play 
a role in tumor cell killing? 
CoHN: We have no direct evidence for a role of plasminogen activator 
in tumor cell killing. Moreover under conditions in which our macro-
phages are secreting very large amounts of plasminogen activator, t hey 
are not tumorcidal. 
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MANNIK: Are activated macrophages indiscriminate killers of adja-
cent cells or are only selected types of cells killed? 
CoHN: We have not looked at a great variety of cell types but we 
know that activated macrophages can kill normal macrophages. They 
can destroy red cells, gn mulocytes, and a variety of cell types other 
than transformed or tumor cells, but only in the very highly activated 
state. It certainly is true that in the experiments of Hibbs and others 
there seems to be a predilection for a killing of tumor cells versus a 
normal counterpart. I am not sure if t his is true for all situations. But 
I know they can kill normal cells under these conditions. 
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